» Articles » PMID: 22179956

The Impact of Frequent and Unrecognized Hypoglycemia on Mortality in the ACCORD Study

Overview
Journal Diabetes Care
Specialty Endocrinology
Date 2011 Dec 20
PMID 22179956
Citations 70
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The aim of this study was to examine the relationship between frequent and unrecognized hypoglycemia and mortality in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) study cohort.

Research Design And Methods: A total of 10,096 ACCORD study participants with follow-up for both hypoglycemia and mortality were included. Hazard ratios (95% CIs) relating the risk of death to the updated annualized number of hypoglycemic episodes and the updated annualized number of intervals with unrecognized hypoglycemia were obtained using Cox proportional hazards regression models, allowing for these hypoglycemia variables as time-dependent covariates and controlling for the baseline covariates.

Results: Participants in the intensive group reported a mean of 1.06 hypoglycemic episodes (self-monitored blood glucose <70 mg/dL or <3.9 mmol/L) in the 7 days preceding their regular 4-month visit, whereas participants in the standard group reported an average of 0.29 episodes. Unrecognized hypoglycemia was reported, on average, at 5.8% of the intensive group 4-month visits and 2.6% of the standard group visits. Hazard ratios for mortality in models including frequency of hypoglycemic episodes were 0.93 (95% CI 0.9-0.97; P < 0.001) for participants in the intensive group and 0.98 (0.91-1.06; P = 0.615) for participants in the standard group. The hazard ratios for mortality in models, including unrecognized hypoglycemia, were not statistically significant for either group.

Conclusions: Recognized and unrecognized hypoglycemia was more common in the intensive group than in the standard group. In the intensive group of the ACCORD study, a small but statistically significant inverse relationship of uncertain clinical importance was identified between the number of hypoglycemic episodes and the risk of death among participants.

Citing Articles

Diabetic Peripheral Neuropathy and Glycemia Risk Index in Type 2 Diabetes: A Cross-Sectional Study.

Tang Y, Zhang P, Li L, Li J Diabetes Metab Syndr Obes. 2024; 17:4191-4198.

PMID: 39526203 PMC: 11550701. DOI: 10.2147/DMSO.S482824.


Major adverse cardiovascular events' reduction and their association with glucose-lowering medications and glycemic control among patients with type 2 diabetes: A retrospective cohort study using electronic health records.

Hsu H, Kocis P, Pichardo-Lowden A, Hwang W J Diabetes. 2024; 16(10):e13604.

PMID: 39431844 PMC: 11492400. DOI: 10.1111/1753-0407.13604.


Follow up care for adults with diabetes treated for severe hypoglycemia by emergency medical Services, 2013-2019.

Rode M, Boggust B, Manggaard J, Myers L, Swanson K, McCoy R Diabetes Res Clin Pract. 2024; 213:111741.

PMID: 38866184 PMC: 11530891. DOI: 10.1016/j.diabres.2024.111741.


Effect of hypoglycemia on baroreflex sensitivity in individuals with type 2 diabetes: implications for autonomic control of cardiovascular function in diabetes.

Haas A, Koefoed A, Easly R, Celli J, Heydarpour M, Bonyhay I Clin Auton Res. 2023; 33(6):727-735.

PMID: 37733159 DOI: 10.1007/s10286-023-00983-5.


Different levels of hypoglycemia in patients with type 2 diabetes, their achieved mean HbA1c vs. all-cause and cardiovascular mortality.

Ooi S, Yeh S, Chang Y, Li C, Chen H PLoS One. 2023; 18(7):e0288360.

PMID: 37494344 PMC: 10370691. DOI: 10.1371/journal.pone.0288360.


References
1.
Zoungas S, Patel A, Chalmers J, de Galan B, Li Q, Billot L . Severe hypoglycemia and risks of vascular events and death. N Engl J Med. 2010; 363(15):1410-8. DOI: 10.1056/NEJMoa1003795. View

2.
Sachs G, Carter R, Holtz L, Smith F, Stump T, Tu W . Cognitive impairment: an independent predictor of excess mortality: a cohort study. Ann Intern Med. 2011; 155(5):300-8. DOI: 10.7326/0003-4819-155-5-201109060-00007. View

3.
Gerstein H, Miller M, Byington R, Goff Jr D, Thomas Bigger J, Buse J . Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008; 358(24):2545-59. PMC: 4551392. DOI: 10.1056/NEJMoa0802743. View

4.
Fanelli C, Paramore D, Hershey T, Terkamp C, OValle F, Craft S . Impact of nocturnal hypoglycemia on hypoglycemic cognitive dysfunction in type 1 diabetes. Diabetes. 1998; 47(12):1920-7. DOI: 10.2337/diabetes.47.12.1920. View

5.
Cryer P . Banting Lecture. Hypoglycemia: the limiting factor in the management of IDDM. Diabetes. 1994; 43(11):1378-89. DOI: 10.2337/diab.43.11.1378. View